Exosome may be the next generation of promising cell-free vaccines

References

• Delany I, Rappuoli R, De Gregorio E. Vaccines for the 21st century. EMBO Mol Med. 2014;6(6):708–11. doi:10.1002/emmm.201403876.
   PubMed Web of Science ®Google Scholar
• Gebre MS, Brito LA, Tostanoski LH, Edwards DK, Carfi A, Barouch DH. Novel approaches for vaccine development. Cell. 2021;184(6):1589–603. doi:10.1016/j.cell.2021.02.030.
   PubMed Web of Science ®Google Scholar
• Sun YF, Pi J, Xu JF. Emerging role of exosomes in tuberculosis: from immunity regulations to vaccine and immunotherapy. Front Immunol. 2021;12:628973. doi:10.3389/fimmu.2021.628973.
   PubMed Web of Science ®Google Scholar
• Tang Y, Zhou Y, Li HJ. Advances in mesenchymal stem cell exosomes: a review. Stem Cell Res Ther. 2021;12(1):71. doi:10.1186/s13287-021-02138-7.
   PubMed Web of Science ®Google Scholar
• Lässer C. Exosomes in diagnostic and therapeutic applications: biomarker, vaccine and RNA interference delivery vehicle. Expert Opin Biol Ther. 2014;15(1):103–17. doi:10.1517/14712598.2015.977250.
   PubMed Web of Science ®Google Scholar
• Amiri A, Bagherifar R, Ansari Dezfouli E, Kiaie SH, Jafari R, Ramezani R. Exosomes as bio-inspired nanocarriers for RNA delivery: preparation and applications. J Transl Med. 2022;20(1):125. doi:10.1186/s12967-022-03325-7.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bi J, Huang J, Tang Y, Du S, Li P. Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications. Int J Nanomed. 2020;15:6917–34. doi:10.2147/IJN.S264498.
   PubMed Web of Science ®Google Scholar
• Greening DW, Xu R, Ji H, Tauro BJ, Simpson RJ. A protocol for exosome isolation and characterization: evaluation of ultracentrifugation, density-gradient separation, and immunoaffinity capture methods. Methods Mol Biol. 2015;1295:179–209. doi:10.1007/978-1-4939-2550-6_15.
   PubMedGoogle Scholar
• Shahabipour F, Banach M, Sahebkar A. Exosomes as nanocarriers for siRNA delivery: paradigms and challenges. Arch Med Sci. 2016;12(6):1324–6. doi:10.5114/aoms.2016.62911.
   PubMed Web of Science ®Google Scholar
• Haney MJ, Klyachko NL, Zhao Y, Gupta R, Plotnikova EG, He Z, Patel T, Piroyan A, Sokolsky M, Kabanov AV, et al. Exosomes as drug delivery vehicles for Parkinson’s disease therapy. J Control Release. 2015;207:18–30. doi:10.1016/j.jconrel.2015.03.033.
   PubMed Web of Science ®Google Scholar
• El Andaloussi S, Lakhal S, Mäger I, Wood MJ. Exosomes for targeted siRNA delivery across biological barriers. Adv Drug Deliv Rev. 2013;65(3):391–7. doi:10.1016/j.addr.2012.08.008.
   PubMed Web of Science ®Google Scholar
• Headland SE, Jones HR, Norling LV, Kim A, Souza PR, Corsiero E, Gil CD, Nerviani A, Dell’accio F, Pitzalis C, et al. Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis. Sci Transl Med. 2015;7(315):315ra190. doi:10.1126/scitranslmed.aac5608.
   PubMed Web of Science ®Google Scholar
• Heusermann W, Hean J, Trojer D, Steib E, von Bueren S, Graff-Meyer A, Genoud C, Martin K, Pizzato N, Voshol J, et al. Exosomes surf on filopodia to enter cells at endocytic hot spots, traffic within endosomes, and are targeted to the ER. J Cell Biol. 2016;213(2):173–84. doi:10.1083/jcb.201506084.
   PubMed Web of Science ®Google Scholar
• Kanlikilicer P. Exosome-related methods and potential use as vaccines. Methods Mol Biol. 2022;2435:35–41. doi:10.1007/978-1-0716-2014-4_4.
   PubMedGoogle Scholar
• Natasha G, Gundogan B, Tan A, Farhatnia Y, Wu W, Rajadas J, Seifalian AM. Exosomes as immunotheranostic nanoparticles. Cli Ther. 2014;36(6):820–9. doi:10.1016/j.clinthera.2014.04.019.
   PubMed Web of Science ®Google Scholar
• El Safadi D, Mokhtari A, Krejbich M, Lagrave A, Hirigoyen U, Lebeau G, Viranaicken W, Krejbich-Trotot P. Exosome-mediated antigen delivery: unveiling novel strategies in viral infection control and vaccine design. Nato Adv Sci Inst Se. 2024;12(3):280. doi:10.3390/vaccines12030280.
   Google Scholar
• Bae S, Brumbaugh J, Bonavida B. Exosomes derived from cancerous and non-cancerous cells regulate the anti-tumor response in the tumor microenvironment. Genes Cancer. 2018;9(3–4):87–100. doi:10.18632/genesandcancer.172.
   PubMedGoogle Scholar
• Hendrix A, Hume AN. Exosome signaling in mammary gland development and cancer. Int J Dev Biol. 2011;55(7–9):879–87. doi:10.1387/ijdb.113391ah.
   PubMed Web of Science ®Google Scholar
• McAndrews KM, Kalluri R. Mechanisms associated with biogenesis of exosomes in cancer. Mol Cancer. 2019;18(1):52. doi:10.1186/s12943-019-0963-9.
   PubMed Web of Science ®Google Scholar
• Milane L, Singh A, Mattheolabakis G, Suresh M, Amiji MM. Exosome mediated communication within the tumor microenvironment. J Control Release. 2015;219:278–94. doi:10.1016/j.jconrel.2015.06.029.
   PubMed Web of Science ®Google Scholar
• Beach A, Zhang HG, Ratajczak MZ, Kakar SS. Exosomes: an overview of biogenesis, composition and role in ovarian cancer. J Ovarian Res. 2014;7(1):14. doi:10.1186/1757-2215-7-14.
   PubMedGoogle Scholar
• He C, Zheng S, Luo Y, Wang B. Exosome theranostics: biology and translational medicine. Theranostics. 2018;8(1):237–55. doi:10.7150/thno.21945.
   PubMed Web of Science ®Google Scholar
• Taghikhani A, Farzaneh F, Sharifzad F, Mardpour S, Ebrahimi M, Hassan ZM. Engineered tumor-derived extracellular vesicles: potentials in cancer immunotherapy. Front Immunol. 2020;11:221. doi:10.3389/fimmu.2020.00221.
   PubMed Web of Science ®Google Scholar
• Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2(8):569–79. doi:10.1038/nri855.
   PubMed Web of Science ®Google Scholar
• Kantarcioglu M. New therapeutic players on the horizon: edible plant derived exosomes. Hepatol Forum. 2021;2(3):89–90. doi:10.14744/hf.2021.2021.ed0002.
   PubMedGoogle Scholar
• Teng Y, Ren Y, Sayed M, Hu X, Lei C, Kumar A, Hutchins E, Mu J, Deng Z, Luo C, et al. Plant-derived exosomal MicroRNAs shape the gut microbiota. Cell Host Microbe. 2018;24(5):637–52.e8. doi:10.1016/j.chom.2018.10.001.
   PubMed Web of Science ®Google Scholar
• Teng Y, Xu F, Zhang X, Mu J, Sayed M, Hu X, Lei C, Sriwastva M, Kumar A, Sundaram K, et al. Plant-derived exosomal microRnas inhibit lung inflammation induced by exosomes SARS-CoV-2 Nsp12. Mol Ther. 2021;29(8):2424–40. doi:10.1016/j.ymthe.2021.05.005.
   PubMed Web of Science ®Google Scholar
• Biadglegne F, König B, Rodloff AC, Dorhoi A, Sack U. Composition and clinical significance of exosomes in tuberculosis: a systematic literature review. J Clin Med. 2021;10(1):145. doi:10.3390/jcm10010145.
   PubMed Web of Science ®Google Scholar
• Malekian F, Shamsian A, Kodam SP, Ullah M. Exosome engineering for efficient and targeted drug delivery: current status and future perspective. J Physiol. 2022;601(22):4853–72. doi:10.1113/JP282799.
   PubMed Web of Science ®Google Scholar
• Gehrmann U, Näslund TI, Hiltbrunner S, Larssen P, Gabrielsson S. Harnessing the exosome-induced immune response for cancer immunotherapy. Semin Cancer Biol. 2014;28:58–67. doi:10.1016/j.semcancer.2014.05.003.
   PubMed Web of Science ®Google Scholar
• Jafari D, Shajari S, Jafari R, Mardi N, Gomari H, Ganji F, Forouzandeh Moghadam M, Samadikuchaksaraei A. Designer Exosomes: a new platform for biotechnology therapeutics. BioDrugs. 2020;34(5):567–86. doi:10.1007/s40259-020-00434-x.
   PubMed Web of Science ®Google Scholar
• Hood JL. Post isolation modification of exosomes for nanomedicine applications. Nanomedicine. 2016;11(13):1745–56. doi:10.2217/nnm-2016-0102.
   PubMed Web of Science ®Google Scholar
• Naseri Z, Oskuee RK, Jaafari MR, Forouzandeh Moghadam M. Exosome-mediated delivery of functionally active miRNA-142-3p inhibitor reduces tumorigenicity of breast cancer in vitro and in vivo. Int J Nanomed. 2018;13:7727–47. doi:10.2147/IJN.S182384.
   PubMed Web of Science ®Google Scholar
• Kooijmans SAA, Aleza CG, Roffler SR, van Solinge WW, Vader P, Schiffelers RM. Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting. J Extracell Vesicles. 2016;5:31053. doi:10.3402/jev.v5.31053.
   PubMed Web of Science ®Google Scholar
• Zhang M, Zang X, Wang M, Li Z, Qiao M, Hu H, Chen D. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges. J Mater Chem B. 2019;7(15):2421–33. doi:10.1039/c9tb00170k.
   PubMed Web of Science ®Google Scholar
• Choi H, Choi Y, Yim HY, Mirzaaghasi A, Yoo J-K, Choi C. Biodistribution of exosomes and engineering strategies for targeted delivery of therapeutic exosomes. Tissue Eng Regen Med. 2021;18(4):499–511. doi:10.1007/s13770-021-00361-0.
   PubMed Web of Science ®Google Scholar
• Longatti A, Schindler C, Collinson A, Jenkinson L, Matthews C, Fitzpatrick L, Blundy M, Minter R, Vaughan T, Shaw M, et al. High affinity single-chain variable fragments are specific and versatile targeting motifs for extracellular vesicles. Nanoscale. 2018;10(29):14230–44. doi:10.1039/c8nr03970d.
   PubMed Web of Science ®Google Scholar
• Liu Q, Li D, Pan X, Liang Y. Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification. J Nanobiotechnol. 2023;21(1). doi:10.1186/s12951-023-02081-0.
   Web of Science ®Google Scholar
• Choi H, Choi K, Kim D-H, Oh B-K, Yim H, Jo S, Choi C. Strategies for targeted delivery of exosomes to the brain: advantages and challenges. Pharmaceutics. 2022;14(3):672. doi:10.3390/pharmaceutics14030672.
   PubMed Web of Science ®Google Scholar
• Wu JY, Li YJ, Wang J, Hu XB, Huang S, Luo S, Xiang D-X. Multifunctional exosome-mimetics for targeted anti-glioblastoma therapy by manipulating protein corona. J Nanobiotechnol. 2021;19(1). doi:10.1186/s12951-021-01153-3.
   Web of Science ®Google Scholar
• Sato YT, Umezaki K, Sawada S, Mukai SA, Sasaki Y, Harada N, Shiku H, Akiyoshi K. Engineering hybrid exosomes by membrane fusion with liposomes. Sci Rep. 2016;6(1). doi:10.1038/srep21933.
   Google Scholar
• Weng Z, Zhang B, Wu C, Yu F, Han B, Li B, Li L. Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer. J Hematol Oncol. 2021;14(1). doi:10.1186/s13045-021-01141-y.
   Web of Science ®Google Scholar
• Li B, Chen X, Qiu W, Zhao R, Duan J, Zhang S, Pan Z, Zhao S, Guo Q, Qi Y, et al. Synchronous disintegration of ferroptosis defense axis via engineered exosome‐conjugated magnetic nanoparticles for glioblastoma therapy. Adv Sci. 2022;9(17). doi:10.1002/advs.202105451.
   Web of Science ®Google Scholar
• Chen H, Wang L, Zeng X, Schwarz H, Nanda HS, Peng X, Zhou Y. Exosomes, a new star for targeted delivery. Front Cell Dev Biol. 2021;9:751079. doi:10.3389/fcell.2021.751079.
   PubMed Web of Science ®Google Scholar
• Sadeghi S, Tehrani FR, Tahmasebi S, Shafiee A, Hashemi SM. Exosome engineering in cell therapy and drug delivery. Inflammopharmacology. 2023;31(1):145–69. doi:10.1007/s10787-022-01115-7.
   PubMed Web of Science ®Google Scholar
• Parada N, Romero-Trujillo A, Georges N, Alcayaga-Miranda F. Camouflage strategies for therapeutic exosomes evasion from phagocytosis. J Adv Res. 2021;31:61–74. doi:10.1016/j.jare.2021.01.001.
   PubMed Web of Science ®Google Scholar
• Ferrero-Andrés A, Closa D, Roselló-Catafau J, Folch-Puy E. Polyethylene glycol 35 (PEG35) modulates exosomal uptake and function. Polymers. 2020;12(12):3044. doi:10.3390/polym12123044.
   PubMed Web of Science ®Google Scholar
• Witwer KW, Buzás EI, Bemis LT, Bora A, Lässer C, Lötvall J, Nolte‐‘t Hoen EN, Piper MG, Sivaraman S, Skog J, et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles. 2013;2(1). doi:10.3402/jev.v2i0.20360.
   PubMedGoogle Scholar
• Théry C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernata nts and biological fluids. Curr Protoc Cell Biol. 2006;30(1). Chapter 3:Unit 3.22. doi:10.1002/0471143030.cb0322s30.
   Google Scholar
• Li J, Zhang Y, Dong PY, Yang GM, Gurunathan S. A comprehensive review on the composition, biogenesis, purification, and multifunctional role of exosome as delivery vehicles for cancer therapy. Biomed Pharmacother. 2023;165:115087. doi:10.1016/j.biopha.2023.115087.
   PubMed Web of Science ®Google Scholar
• Lin S, Yu Z, Chen D, Wang Z, Miao J, Li Q, Zhang D, Song J, Cui D. Progress in microfluidics-based exosome separation and detection technologies for diagnostic applications. Small. 2020;16(9):e1903916. doi:10.1002/smll.201903916.
   PubMed Web of Science ®Google Scholar
• Chen J, Li P, Zhang T, Xu Z, Huang X, Wang R, Du L. Review on strategies and technologies for exosome isolation and purification. Front Bioeng Biotechnol. 2022;9:811971. doi:10.3389/fbioe.2021.811971.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Liu G, Li J. Recent progress on the isolation and detection methods of exosomes. Chem Asian J. 2020;15(23):3973–82. doi:10.1002/asia.202000873.
   PubMed Web of Science ®Google Scholar
• Konoshenko MY, Lekchnov EA, Vlassov AV, Laktionov PP. Isolation of extracellular vesicles: general methodologies and latest trends. Biomed Res Int. 2018;2018:8545347. doi:10.1155/2018/8545347.
   PubMed Web of Science ®Google Scholar
• Kamerkar S, LeBleu VS, Sugimoto H, Yang S, Ruivo CF, Melo SA, Lee JJ, Kalluri R. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546(7659):498–503. doi:10.1038/nature22341.
   PubMed Web of Science ®Google Scholar
• Haraszti RA, Miller R, Stoppato M, Sere YY, Coles A, Didiot MC, Wollacott R, Sapp E, Dubuke ML, Li X, et al. Exosomes produced from 3D cultures of MSCs by tangential flow filtration show higher yield and improved activity. Mol Ther. 2018;26(12):2838–47. doi:10.1016/j.ymthe.2018.09.015.
   PubMed Web of Science ®Google Scholar
• Sidhom K, Obi PO, Saleem A. A review of exosomal isolation methods: is size exclusion chromatography the best option? Int J Mol Sci. 2020;21(18):6466. doi:10.3390/ijms21186466.
   PubMed Web of Science ®Google Scholar
• Wang X, Xia J, Yang L, Dai J, He L. Recent progress in exosome research: isolation, characterization and clinical applications. Cancer Gene Ther. 2023;30(8):1051–65. doi:10.1038/s41417-023-00617-y.
   PubMed Web of Science ®Google Scholar
• Batrakova EV, Kim MS. Using exosomes, naturally-equipped nanocarriers, for drug delivery. J Control Release. 2015;219:396–405. doi:10.1016/j.jconrel.2015.07.030.
   PubMed Web of Science ®Google Scholar
• Coumans FAW, Brisson AR, Buzas EI, Dignat-George F, Drees EEE, El-Andaloussi S, Emanueli C, Gasecka A, Hendrix A, Hill AF, et al. Methodological guidelines to study extracellular vesicles. Circ Res. 2017;120(10):1632–48. doi:10.1161/circresaha.117.309417.
   PubMed Web of Science ®Google Scholar
• Gurunathan S, Kang MH, Jeyaraj M, Qasim M, Kim JH. Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. Cells. 2019;8(4):307. doi:10.3390/cells8040307.
   PubMed Web of Science ®Google Scholar
• Fitzgerald J, Leonard P, Darcy E, Sharma S, O’Kennedy R. Immunoaffinity chromatography: concepts and applications. Methods Mol Biol. 2017;1485:27–51. doi:10.1007/978-1-4939-6412-3_3.
   PubMedGoogle Scholar
• Kimiz-Gebologlu I, Oncel SS. Exosomes: large-scale production, isolation, drug loading efficiency, and biodistribution and uptake. J Control Release. 2022;347:533–43. doi:10.1016/j.jconrel.2022.05.027.
   PubMed Web of Science ®Google Scholar
• Jiang X, Jing W, Zheng L, Liu S, Wu W, Sui G. A continuous-flow high-throughput microfluidic device for airborne bacteria PCR detection. Lab Chip. 2014;14(4):671–6. doi:10.1039/c3lc50977j.
   PubMed Web of Science ®Google Scholar
• Tschuschke M, Kocherova I, Bryja A, Mozdziak P, Angelova Volponi A, Janowicz K, Sibiak R, Piotrowska-Kempisty H, Iżycki D, Bukowska D, et al. Inclusion biogenesis, methods of isolation and clinical application of human cellular exosomes. J Clin Med. 2020;9(2):436. doi:10.3390/jcm9020436.
   PubMed Web of Science ®Google Scholar
• Lai JJ, Chau ZL, Chen SY, Hill JJ, Korpany KV, Liang NW, Lin L-H, Lin Y-H, Liu JK, Liu Y-C, et al. Exosome processing and characterization approaches for research and technology development. Adv Sci. 2022;9(15). doi:10.1002/advs.202103222.
   Web of Science ®Google Scholar
• Yu D, Li Y, Wang M, Gu J, Xu W, Cai H, Fang X, Zhang X. Exosomes as a new frontier of cancer liquid biopsy. Mol Cancer. 2022;21(1):56. doi:10.1186/s12943-022-01509-9.
   PubMed Web of Science ®Google Scholar
• Butreddy A, Kommineni N, Dudhipala N. Exosomes as naturally occurring vehicles for delivery of biopharmaceuticals: insights from drug delivery to clinical perspectives. Nanomaterials. 2021;11(6):1481. doi:10.3390/nano11061481.
   Web of Science ®Google Scholar
• Yang B, Chen Y, Shi J. Exosome biochemistry and advanced nanotechnology for next‐generation theranostic platforms. Adv Mater. 2019;31(2). doi:10.1002/adma.201802896.
   Web of Science ®Google Scholar
• Chaput N, Schartz NEC, Andre F, Zitvogel L. Exosomes for immunotherapy of cancer. Adv Exp Med Biol. 2003;532:215–21. doi:10.1007/978-1-4615-0081-0_17.
   PubMed Web of Science ®Google Scholar
• Cheng Q, Shi X, Han M, Smbatyan G, Lenz HJ, Zhang Y. Reprogramming exosomes as nanoscale controllers of cellular immunity. J Am Chem Soc. 2018;140(48):16413–17. doi:10.1021/jacs.8b10047.
   PubMed Web of Science ®Google Scholar
• Shi X, Cheng Q, Hou T, Han M, Smbatyan G, Lang JE, Epstein AL, Lenz H-J, Zhang Y. Genetically engineered cell-derived nanoparticles for targeted breast cancer immunotherapy. Mol Ther. 2020;28(2):536–47. doi:10.1016/j.ymthe.2019.11.020.
   PubMed Web of Science ®Google Scholar
• Qazi KR, Gehrmann U, Domange Jordö E, Karlsson MC, Gabrielsson S. Antigen-loaded exosomes alone induce Th1-type memory through a B-cell-dependent mechanism. Blood. 2009;113(12):2673–83. doi:10.1182/blood-2008-04-153536.
   PubMed Web of Science ®Google Scholar
• Delcayre A, Estelles A, Sperinde J, Roulon T, Paz P, Aguilar B, Villanueva J, Khine S, Le Pecq JB. Exosome display technology: applications to the development of new diagnostics and therapeutics. Blood Cells Mol Dis. 2005;35(2):158–68. doi:10.1016/j.bcmd.2005.07.003.
   PubMed Web of Science ®Google Scholar
• Greening DW, Gopal SK, Xu R, Simpson RJ, Chen W. Exosomes and their roles in immune regulation and cancer. Semin Cell Dev Biol. 2015;40:72–81. doi:10.1016/j.semcdb.2015.02.009.
   PubMed Web of Science ®Google Scholar
• Naseri M, Bozorgmehr M, Zöller M, Ranaei Pirmardan E, Madjd Z. Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy. Oncoimmunology. 2020;9(1):1779991. doi:10.1080/2162402x.2020.1779991.
   PubMed Web of Science ®Google Scholar
• Burke M, Choksawangkarn W, Edwards N, Ostrand-Rosenberg S, Fenselau C. Exosomes from myeloid-derived suppressor cells carry biologically active proteins. J Proteome Res. 2014;13(2):836–43. doi:10.1021/pr400879c.
   PubMed Web of Science ®Google Scholar
• McNulty S, Colaco CA, Blandford LE, Bailey CR, Baschieri S, Todryk S. Heat-shock proteins as dendritic cell-targeting vaccines–getting warmer. Immunology. 2013;139(4):407–15. doi:10.1111/imm.12104.
   PubMed Web of Science ®Google Scholar
• Nie X, Shi C, Chen X, Yu C, Jiang Z, Xu G, Lin Y, Tang M, Luan Y. A single-shot prophylactic tumor vaccine enabled by an injectable biomembrane hydrogel. Acta Biomater. 2023;169:306–16. doi:10.1016/j.actbio.2023.08.010.
   PubMed Web of Science ®Google Scholar
• Mears R, Craven RA, Hanrahan S, Totty N, Upton C, Young SL, Patel P, Selby PJ, Banks RE. Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. Proteomics. 2004;4(12):4019–31. doi:10.1002/pmic.200400876.
   PubMed Web of Science ®Google Scholar
• Chaput N, Théry C. Exosomes: immune properties and potential clinical implementations. Semin Immunopathol. 2011;33(5):419–40. doi:10.1007/s00281-010-0233-9.
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D, Ricciardi-Castagnoli P, Raposo G, Amigorena S. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med. 1998;4(5):594–600. doi:10.1038/nm0598-594.
   PubMed Web of Science ®Google Scholar
• Pitt JM, André F, Amigorena S, Soria JC, Eggermont A, Kroemer G, Zitvogel L. Dendritic cell–derived exosomes for cancer therapy. J Clin Invest. 2016;126(4):1224–32. doi:10.1172/jci81137.
   PubMed Web of Science ®Google Scholar
• Kowal J, Tkach M. Dendritic cell extracellular vesicles. Int Rev Cell Mol Biol. 2019;349:213–49. doi:10.1016/bs.ircmb.2019.08.005.
   PubMed Web of Science ®Google Scholar
• Zhang B, Yin Y, Lai RC, Lim SK. Immunotherapeutic potential of extracellular vesicles. Front Immunol. 2014;5:518. doi:10.3389/fimmu.2014.00518.
   PubMed Web of Science ®Google Scholar
• Lindenbergh MFS, Stoorvogel W. Antigen presentation by extracellular vesicles from professional antigen-presenting cells. Annu Rev Immunol. 2018;36(1):435–59. doi:10.1146/annurev-immunol-041015-055700.
   PubMed Web of Science ®Google Scholar
• Hsu DH, Paz P, Villaflor G, Rivas A, Mehta-Damani A, Angevin E, Zitvogel L, Le Pecq J-B. Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptides. J Immunother. 2003;26(5):440–50. doi:10.1097/00002371-200309000-00007.
   PubMed Web of Science ®Google Scholar
• Viaud S, Théry C, Ploix S, Tursz T, Lapierre V, Lantz O, Zitvogel L, Chaput N. Dendritic cell-derived exosomes for cancer immunotherapy: what’s next? Cancer Research. 2010;70(4):1281–5. doi:10.1158/0008-5472.Can-09-3276.
   PubMed Web of Science ®Google Scholar
• Chaput N, Taïeb J, Schartz NEC, André F, Angevin E, Zitvogel L. Exosome-based immunotherapy. Cancer Immunol Immunother. 2004;53(3):234–9. doi:10.1007/s00262-003-0472-x.
   PubMed Web of Science ®Google Scholar
• Syn NL, Wang L, Chow EKH, Lim CT, Goh BC. Exosomes in cancer nanomedicine and immunotherapy: prospects and challenges. Trends Biotechnol. 2017;35(7):665–76. doi:10.1016/j.tibtech.2017.03.004.
   PubMed Web of Science ®Google Scholar
• Viaud S, Terme M, Flament C, Taieb J, André F, Novault S, Escudier B, Robert C, Caillat-Zucman S, Tursz T, et al. Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Rα. PLOS ONE. 2009;4(3):e4942. doi:10.1371/journal.pone.0004942.
   PubMed Web of Science ®Google Scholar
• Lu Z, Zuo B, Jing R, Gao X, Rao Q, Liu Z, Qi H, Guo H, Yin H. Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models. J Hepatol. 2017;67(4):739–48. doi:10.1016/j.jhep.2017.05.019.
   PubMed Web of Science ®Google Scholar
• Veerman RE, Güçlüler Akpinar G, Eldh M, Gabrielsson S. Immune cell-derived extracellular vesicles – functions and therapeutic applications. Trends Mol Med. 2019;25(5):382–94. doi:10.1016/j.molmed.2019.02.003.
   PubMed Web of Science ®Google Scholar
• Munich S, Sobo-Vujanovic A, Buchser WJ, Beer-Stolz D, Vujanovic NL. Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands. Oncoimmunology. 2012;1(7):1074–83. doi:10.4161/onci.20897.
   PubMed Web of Science ®Google Scholar
• Robbins PD, Morelli AE. Regulation of immune responses by extracellular vesicles. Nat Rev Immunol. 2014;14(3):195–208. doi:10.1038/nri3622.
   PubMed Web of Science ®Google Scholar
• Wieckowski E, Whiteside TL. Human tumor-derived vs dendritic cell-derived exosomes have distinct biologic roles and molecular profiles. Immunol Res. 2006;36(1–3):247–54. doi:10.1385/ir:36:1:247.
   PubMed Web of Science ®Google Scholar
• Inamdar S, Nitiyanandan R, Rege K. Emerging applications of exosomes in cancer therapeutics and diagnostics. Bioeng Transl Med. 2017;2(1):70–80. doi:10.1002/btm2.10059.
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Vázquez C, Villarroya-Beltri C, Mittelbrunn M, Sánchez-Madrid F. Transfer of extracellular vesicles during immune cell-cell interactions. Immunol Rev. 2013;251(1):125–42. doi:10.1111/imr.12013.
   PubMed Web of Science ®Google Scholar
• Wen C, Seeger RC, Fabbri M, Wang L, Wayne AS, Jong AY. Biological roles and potential applications of immune cell-derived extracellular vesicles. J Extracell Vesicles. 2017;6(1):1400370. doi:10.1080/20013078.2017.1400370.
   PubMed Web of Science ®Google Scholar
• Peters PJ, Geuze HJ, Van der Donk HA, Slot JW, Griffith JM, Stam NJ, Clevers HC, Borst J. Molecules relevant for T cell-target cell interaction are present in cytolytic granules of human T lymphocytes. Eur J Immunol. 1989;19(8):1469–75. doi:10.1002/eji.1830190819.
   PubMed Web of Science ®Google Scholar
• Zhu L, Kalimuthu S, Gangadaran P, Oh JM, Lee HW, Baek SH, Jeong SY, Lee S-W, Lee J, Ahn B-C, et al. Exosomes derived from natural killer cells exert therapeutic effect in melanoma. Theranostics. 2017;7(10):2732–45. doi:10.7150/thno.18752.
   PubMed Web of Science ®Google Scholar
• Cheng L, Wang Y, Huang L. Exosomes from M1-polarized macrophages potentiate the cancer vaccine by creating a pro-inflammatory microenvironment in the lymph node. Mol Ther. 2017;25(7):1665–75. doi:10.1016/j.ymthe.2017.02.007.
   PubMed Web of Science ®Google Scholar
• Wang P, Wang H, Huang Q, Peng C, Yao L, Chen H, Qiu Z, Wu Y, Wang L, Chen W, et al. Exosomes from M1-polarized macrophages enhance paclitaxel antitumor activity by activating macrophages-mediated inflammation. Theranostics. 2019;9(6):1714–27. doi:10.7150/thno.30716.
   PubMed Web of Science ®Google Scholar
• Behzadi E, Hosseini HM, Halabian R, Fooladi AAI. Macrophage cell-derived exosomes/staphylococcal enterotoxin B against fibrosarcoma tumor. Microb Pathog. 2017;111:132–8. doi:10.1016/j.micpath.2017.08.027.
   PubMed Web of Science ®Google Scholar
• Sabanovic B, Piva F, Cecati M, Giulietti M. Promising extracellular vesicle-based vaccines against viruses, including SARS-CoV-2. Biology. 2021;10(2):94. doi:10.3390/biology10020094.
   PubMedGoogle Scholar
• Yoo KH, Thapa N, Kim BJ, Lee JO, Jang YN, Chwae YJ, Kim J. Possibility of exosome‑based coronavirus disease 2019 vaccine (review). Mol Med Rep. 2022;25(1):26. doi:10.3892/mmr.2021.12542.
   PubMed Web of Science ®Google Scholar
• Zani-Ruttenstock E, Antounians L, Khalaj K, Figueira RL, Zani A. The role of exosomes in the treatment, prevention, diagnosis, and pathogenesis of COVID-19. Eur J Pediatr Surg. 2021;31(4):326–34. doi:10.1055/s-0041-1731294.
   PubMedGoogle Scholar
• Tsai SJ, Atai NA, Cacciottolo M, Nice J, Salehi A, Guo C, Sedgwick A, Kanagavelu S, Gould SJ. Exosome-mediated mRNA delivery in vivo is safe and can be used to induce SARS-CoV-2 immunity. J Biol Chem. 2021;297(5):101266. doi:10.1016/j.jbc.2021.101266.
   PubMed Web of Science ®Google Scholar
• Kuate S, Cinatl J, Doerr HW, Uberla K. Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies. Virology. 2007;362(1):26–37. doi:10.1016/j.virol.2006.12.011.
   PubMed Web of Science ®Google Scholar
• Mondal J, Pillarisetti S, Junnuthula V, Saha M, Hwang SR, Park IK, Lee Y-K. Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications. J Control Release. 2023;353:1127–49. doi:10.1016/j.jconrel.2022.12.027.
   PubMed Web of Science ®Google Scholar